Проблема резистентности Helicobacter pylori к кларитромицину

1. Захарова Н.В. Helicobacter pylori-ассоциированные хронические гастриты (патогенез, возможности дифференцированной терапии): Автореф. дис. … докт. мед. наук. СПб., 2009.
2. Консолар М. Новые подходы к диагностике и элиминации Helicobacter pylori при язвенной патологии желудочно-кишечного тракта. Автореф. дис. … канд. биол. наук. Казань, 2007.
3. Корниенко Е. А., Паролова Н.И. Проблема антибиотикорезистентности Helicobacter pylori у детей и выбор терапии. Вопросы современной педиатрии. 2006; 5 (5): 1–4.
4. . Кудрявцева Л.В, Исаков В. А. Резистентность H. pylori к амоксициллину, кларитромицину и метронидазолу в России и ее клиническое значение. Материалы II международного симпозиума «Диагностика и лечение заболеваний, ассоциированных с Helicobacter pylori». М., 1999.
5. . Кудрявцева Л.В., Исаков В. А., Иваников И.О. и др. Резистентность H.pylori к метронидазолу, кларитромицину и амоксициллину в Москве, Санкт-Петербурге и Абакане в 2001 г. Педиатрия. 2002; 2 (приложение): 61–3.
6. . Кудрявцева Л.В., Щербаков П. Л., Иваников И.О., Говорун В.М. Helicobacter pylori-инфекция: современные   аспекты диагностики и терапии. Пособие для врачей. М., 2004.
7. Мишкина Т.В. Диагностическая значимость метода полимеразной цепной реакции при генотипировании Helicobacter pylori у детей с хронической гастродуоденальной патологией. Автореф. дис. … канд. мед. наук. СПб., 2007.
8. Паролова Н.И. Сравнительная оценка эффективности эрадикационной терапии инфекции Нelicobacter pylori у детей: Автореф. дис. … канд. мед. наук. СПб., 2007.
9. Рачина С. А., Страчунский Л.С., Козлов Р.С. Кларитромицин: есть ли потенциал для клинического применения в XXI веке? Клин. микробиол. антимикроб. химиотер. 2005; 4: 369–92.
10. Страчунский Л.С., Козлов С.Н. Макролиды в современной клинической практике. Смоленск: Русич, 1998.
11. Успенский Ю.П., Барышникова Н.В. Оптимизация диагностики и лечения больных заболеваниями, ассоциированными с инфекцией Helicobacter pylory/усовершенствованная медицинская технология.. СПб., 2008.
12. Aboderin O, Abdu A, Odetoyin B et al. Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria. Afr Health Sci 2007; 3: 143–7.
13. Boyanova L, Gergova G, Nikolov R et al. Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods. Diagn Microbiol Infect Dis 2008; 4: 409–15.
14. Buza? s G, Lotz G, Kiss A et al. The epidemiology of clarithromycin resistance of Helicobacter pylori infection in Hungary. Orv Hetil 2007; 31: 1461–7.
15. Cars O, Molstad S, Melander Z. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851–3.
16. Chen S, Li Y, Yu C. Oligonucleotide microarray: a new rapid method for screening the 23S rRNA gene of Helicobacter pylori for single nucleotide polymorphisms associated with clarithromycin resistance. J Gastroenterol Hepatol 2008; 1: 126–31.
17. Chisholm S, Teare E, Davies K, Owen R. Surveillance of primary antibiotic resistance of Helicobacter pylori at centres in England and Wales over a six-year period (2000–2005). Euro Surveill 2007; 7: E3–4.
18. Debets-Ossenkopp Y, Herscheid A, Pot R et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother 1999; 43: 511–5.
19. De Francesco V, Margiotta M, Zullo A et al. Clarithromycinresistant genotypes and eradication of Helicobacter pylori. Ann Intern Med 2006; 2: 94–100.
20. Duck W, Sobel J, Pruckler J et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis 2004; 6: 1088–94.
21. Elviss N, Owen R, Xerry J et al. Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J Antimicrob Chemother 2004; 2: 435–40.
22. Feydt-Schmidt A, Russmann H, Lehn N et al. Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin-susceptible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children. Aliment Pharmacol Ther 2002; 16: 2073–9.
23. Filipec Kanizaj T, Katicic M, Skurla B et al. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens. Helicobacter 2009; 1: 29–35.
24. Fontana C, Favaro M, Minelli S et al. New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob. Agents Chemother 2002; 12: 3765–9.
25. Garrido L, Toledo H. Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene. Helicobacter 2007; 5: 505–9.
26. Hooton C, Dempsey C, Keohane J et al. Helicobacter pylori: prevalence of antimicrobial resistance in clinical isolates. Br J Biomed Sci 2006; 3: 113–6.
27. Huang L, Zhuang M, Gu C et al. Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents. Zhongguo. Dang Dai Er Ke Za Zhi 2009; 3: 210–2.
28. Hung KH, Sheu BS, Chang WL et al. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Helicobacter 2009; 1: 61–5.
29. Janssen M, Hendrikse L, de Boer S et al. Helicobacter pylori antibiotic resistance in a Dutch region: trends over time. Neth J Med 2006; 6: 191–5.
30. Khan R, Nahar S, Sultana J et al. T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob Agents Chemother 2004; 9: 3567–9.
31. Kim JJ, Kim JG, Kwon D et al. Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 2003; 3: 202–6.
32. Kim JM, Kim JS, Kim N et al. Gene mutations of 23S rRNA associated with clarithromycin resistance in Helicobacter pylori strains isolated from Korean patients. J Microbiol Biotechnol 2008; 9: 1584–9.
33. Kohanteb J, Bazargani A, Saberi-Firoozi M, Mobasser A. Antimicrobial susceptibility testing of Helicobacter pylori to selected agents by agar dilution method in Shiraz-Iran. Indian J Med Microbiol 2007; 4: 374–7.
34. Koivisto T, Rautelin H, Voutilainen M et al. Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population. Aliment Pharmacol Ther 2005; 9: 1009–17.
35. Kuwahara H, Kariu T, Fang J, Maeda H. Generation of drug-resistant mutants of Helicobacter pylori in the presence of peroxynitrite, a derivative of nitric oxide, at pathophysiological concentration. Microbiol Immunol 2009; 1: 1–7.
36. Leclercq R, Courvalin P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother 2002; 9: 2727–34.
37. Liu Z, Shen J, Zhang L et al. Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history. BMC Microbiol 2008; 8: 81.
38. Lee J, Shin J, Roe I et al. Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults. Antimicrob Agents Chemother 2005; 4: 1600–3.
39. McMahon B, Hennessy T, Bensler J et al. The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann Intern Med 2003; 6: 463–9.
40. Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 9: 1374–84.
41. Sugimoto M, Furuta T, Kodaira C et al. The Degree and Duration of Acid Suppression During Treatment Is Related to Helicobacter pylori Eradication. DDW, 2008.
42. Moder K, Layer F, Ko nig W, Ko nig B. Rapid screening of clarithromycin resistance in Helicobacter pylori by pyrosequencing. J Med Microbiol 2007t; 56: 1370–6.
43. Mohammadi M, Doroud D, Mohajerani N, Massarrat S. Helicobacter pylori antibiotic resistance in Iran. World J Gastroenterol 2005; 38: 6009–13.
44. Noguchi N, Rimbara E, Kato A. Detection of mixed clarithromycin-resistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces. J Med Microbiol 2007; 9: 1174–80.
45. Oyedeji K, Smith S, Coker A, Arigbabu A. Antibiotic susceptibility patterns in Helicobacter pylori strains from patients with upper gastrointestinal pathology in western Nigeria. Br J Biomed Sci 2009; 1: 10–3.
46. Posteraro P, Branca G, Sanguinetti M et al. Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCRbased denaturing HPLC assay. J Antimicrob Chemother 2006; 1: 71–8.
47. Rafeey M, Ghotaslou R, Nikvash S, Hafez A. Primary resistance in Helicobacter pylori isolated in children from Iran. J Infect Chemother 2007; 5: 291–5.
48. Rimbara E, Noguchi N, Kawai T, Sasatsu M. Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori. Antimicrob Agents Chemother 2008; 9: 3465–6.
49. Schabereiter-Gurtner C, Hirschl A, Dragosics B et al. Novel Real-Time PCR Assay for Detection of Helicobacter pylori Infection and Simultaneous Clarithromycin Susceptibility Testing of Stool and Biopsy Specimens. J Clin Microbiol 2004; 42: 4512–8.
50. Sezgin O, Aslan G, Altintas E et al. Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey. Turk J Gastroenterol 2008; 3: 163–7.
51. Sung H, Chung H, Kim M, Lee G. Clinical Usefulness of Antimicrobial Susceptibility Test for Helicobacter pylori. Korean J Lab Med 2006; 3: 179–84.
52. Toracchio S, Aceto G, Mariani-Costantini R et al. Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori. Helicobacter 2004; 5: 396–9.
53. Tu zu n Y, Bayan K, Yilmaz S et al. The prevalence of primary and secondary Helicobacter pylori resistance to clarithromycin and probable contributing cofactors: data from southeastern Anatolia. Hepatogastroenterol 2008; 81: 289–93.
54. Van Doorn L, Glupczynski Y, Kusters J et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 2001; 5: 1500–4.
55. Yakoob J, Fan X, Hu G, Zhang Z. Genetic and phenotype changes following in vitro interactions between Helicobacter pylori strains. J Gastroenterol Hepatol 2004; 6: 626–31.
56. Zullo A, Perna F, Hassan C et al. Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol Ther 2007; 12: 1429–34.